<--- Back to Details
First PageDocument Content
Pharmacology / Biotechnology / Health care / Recombinant proteins / Pharmaceutical industry / Immunosuppressants / Amgen / Biosimilar / Etanercept / Filgrastim / Hospira / Generic drug
Pharmacology
Biotechnology
Health care
Recombinant proteins
Pharmaceutical industry
Immunosuppressants
Amgen
Biosimilar
Etanercept
Filgrastim
Hospira
Generic drug

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

Add to Reading List

Source URL: www.harvard-jlpp.com

Download Document from Source Website

File Size: 305,00 KB

Share Document on Facebook

Similar Documents

Amgen-Scholars-US Program-OCT2016

Amgen-Scholars-US Program-OCT2016

DocID: 1vl38 - View Document

Amgen-Scholars-Program-Japan-Translated-OCT2016

Amgen-Scholars-Program-Japan-Translated-OCT2016

DocID: 1v8Op - View Document

Amgen-Scholars-Program-Japan-Translated-OCT2016

Amgen-Scholars-Program-Japan-Translated-OCT2016

DocID: 1uS7i - View Document

Student Guide Amgen Scholars Programme Ludwig-Maximilians University Munich Undergraduate Summer Research 2018  European LMU Amgen Scholars Programme

Student Guide Amgen Scholars Programme Ludwig-Maximilians University Munich Undergraduate Summer Research 2018 European LMU Amgen Scholars Programme

DocID: 1uMs7 - View Document

Amgen-Scholars-Japan-Program-A4-OCT2016

Amgen-Scholars-Japan-Program-A4-OCT2016

DocID: 1uKFN - View Document